Pathstone Holdings LLC Increases Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Pathstone Holdings LLC grew its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.2% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 33,820 shares of the company’s stock after purchasing an additional 1,063 shares during the quarter. Pathstone Holdings LLC’s holdings in GE HealthCare Technologies were worth $3,174,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of GEHC. LMR Partners LLP purchased a new position in GE HealthCare Technologies in the 3rd quarter valued at approximately $7,387,000. AMG National Trust Bank boosted its holdings in shares of GE HealthCare Technologies by 35.0% in the third quarter. AMG National Trust Bank now owns 17,121 shares of the company’s stock worth $1,607,000 after acquiring an additional 4,439 shares during the period. Aljian Capital Management LLC purchased a new position in shares of GE HealthCare Technologies in the third quarter valued at $847,000. Swiss National Bank raised its stake in shares of GE HealthCare Technologies by 0.5% during the 3rd quarter. Swiss National Bank now owns 1,287,187 shares of the company’s stock valued at $120,802,000 after purchasing an additional 6,500 shares during the period. Finally, Thrivent Financial for Lutherans lifted its holdings in GE HealthCare Technologies by 16.5% during the 3rd quarter. Thrivent Financial for Lutherans now owns 25,408 shares of the company’s stock worth $2,385,000 after purchasing an additional 3,602 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Up 0.5 %

Shares of NASDAQ:GEHC opened at $82.44 on Monday. The firm has a market capitalization of $37.66 billion, a P/E ratio of 22.65, a P/E/G ratio of 2.94 and a beta of 1.24. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The stock has a 50 day moving average price of $88.35 and a 200-day moving average price of $83.62. GE HealthCare Technologies Inc. has a 52-week low of $66.39 and a 52-week high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The business had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. During the same quarter in the previous year, the firm posted $0.99 earnings per share. GE HealthCare Technologies’s quarterly revenue was up .9% on a year-over-year basis. As a group, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.29 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.15%. The ex-dividend date of this dividend was Friday, October 18th. GE HealthCare Technologies’s payout ratio is 3.85%.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the sale, the chief executive officer now directly owns 24,298 shares in the company, valued at approximately $2,101,291.04. This trade represents a 12.83 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.27% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on GEHC. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lowered their target price for the stock from $84.00 to $74.00 in a research note on Thursday, September 26th. JPMorgan Chase & Co. started coverage on shares of GE HealthCare Technologies in a research report on Monday, September 9th. They set a “neutral” rating and a $90.00 price target for the company. Evercore ISI increased their price objective on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. Finally, Stifel Nicolaus boosted their target price on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research report on Monday, September 30th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $94.36.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.